Regulation of hepatic micro circulation by hepatic stellate cell-Application of NAC to liver failure
Regulation of hepatic micro circulation by hepatic stellate cell-Application of NAC to liver failure
批准号:
13557100
负责人:
SHIMAHARA Yasuyuki
金额:
$8.64万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Hepatic stellate cell. is known to regulate hepatic sinusoidal blood flow through its contraction and relaxation. When it is contracted by activation, sinusoidal blood flow is reduced. Therefore, it is considered that regulation of activation of hepatic stellate cell can be a potential strategy to improve hepatic microcirculation. We have clarified in TAA-induced cirrhosis model of rats that N-acetyl-L-cysteine (NAC) has a powerful effect on prevention of hepatic stellate cell activation and progress of fibrosis. In such model, microcirculation was well maintained. Rock/Rho kinase inhibitor, Y-27632 is also known to prevent activation of hepatic stellate cell and prevent fibrosis. In this study, we have examined whether Y-27632 has an effect on improvement of hepatic microcirculation. We have investigated it in ischemia/reperfusion model of rat liver using hemi-lateral clamp of the liver. Y-27632 protected ischemia/reperfusion-induced injury of the liver through remarkable improvement of hepatic microcirculation, which was observed by intravital microscopy. Diamiter of sinusoid and postsinusoidal venule, sinusoidal :perfusion rate were maintained as compared to sham group. Adherence of leucocytes in the sinusoid and postsinusoidal venule was much less, which results also in protection of disturbance of the blood flow. Y-27632 also exhibited to improve disturbance of microcirculation due to endotoxemia. Tioredoxin has an effect of antioxidant like NAC. We clarified that thioredoxin prevents hepatic fibrosis in the chronic liver injury model and also protect hepatic cell death in acute hepatitis model.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shimahara-Y: "Significance of serum type IV collagen level of hepatectomized patients with chronic liver damage."World-J-Surg. (印刷中).
Shimahara-Y:“患有慢性肝损伤的肝切除患者血清 IV 型胶原水平的意义。”World-J-Surg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Significance of serum type IV collagen level of hepatectomized patients with chronic liver damage.
慢性肝损伤肝切除患者血清IV型胶原水平的意义
DOI:
--
发表时间:
2002
期刊:
World-J-Surg. 26(4)
影响因子:
--
作者:
[Shimahara Y]
通讯作者:
Shimahara Y
The interaction between hepatocytes and steate cells on individual cell proliferation and differentiation.
肝细胞和脂肪细胞之间的相互作用对个体细胞增殖和分化的影响。
DOI:
--
发表时间:
2001
期刊:
Cells of Hepatic Sinusoid 8
影响因子:
--
作者:
[Uyama N]
通讯作者:
Uyama N
Uyama-N: "Regulation of Cultured Rat Hepatocyte Proliferation by Stellate Cells"Journal of Hepatology. 36. 590-599 (2002)
Uyama-N:“星状细胞对培养大鼠肝细胞增殖的调节”肝脏病学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Okuyama-H: "Regulation of cell growth by redo-mediated extracellular proteolysis of platelet-derived growth factor receptor beta."J Biol Chem. 276(30). 28274-28280 (2001)
Okuyama-H:“通过重做介导的血小板衍生生长因子受体β的细胞外蛋白水解来调节细胞生长。”《生物化学》杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 19 条
Development of perioperative management for hepatic resection based on the stellate cell function
-
批准号:14370355
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.9万
-
财政年份:2002
-
负责人:SHIMAHARA Yasuyuki
-
依托单位:
Strategy for Liver Failure by Regulating Hepatic Microcirculation through Hepatic Stellate Cell Activatity
-
批准号:12470238
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.09万
-
财政年份:2000
-
负责人:SHIMAHARA Yasuyuki
-
依托单位:
Aspect of Strategy for Liver Failure by Regelating Hepatic Stellate Cell Activation
-
批准号:11557084
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.68万
-
财政年份:1999
-
负责人:SHIMAHARA Yasuyuki
-
依托单位:
New Strategy for Liver Failure by Regulating Hepatic Extracellular Matrix
-
批准号:10470240
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.41万
-
财政年份:1998
-
负责人:SHIMAHARA Yasuyuki
-
依托单位:
海外基金